Overall, our data suggest that the TTNmv creates an EP substrate for AF by modulating IKs activity, in part by increasing the interaction between the KCNQ1-KCNE1 complex and FHL2 (Figure 5E). Here, FHL2 is linked to atrial fibrillation.